Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Completed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors

In brief

This phase I trial is studying the side effects and best dose of vandetanib when given together with radiation therapy in treating young patients with newly diagnosed diffuse brain stem glioma.

Key facts

Study ID

NCT00472017

Run by

St. Jude Children's Research Hospital

People needed

35

Starts

2007-04-01

Expected to finish

2011-10-01

Last updated by the study team

2012-10-15

Who can join

Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.